Homeopathic Calendula Oil Recalled for Manufacturing Practice Violations
Atlantic Management Resources voluntarily recalls Menastil homeopathic calendula oil due to cGMP deviations. The 26 bottles (Lot A-01) were distributed nationwide and to Australia.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall for manufacturing practice deviations with no reported illnesses, injuries, or hospitalization. The source text indicates no actual harm, making this a voluntary precautionary recall for a quality control issue.
Plain-English summary
Atlantic Management Resources Ltd. has voluntarily recalled Menastil, A Homeopathic Formula, Calendula Oil, packaged in 1/8 fl. oz. (3.5 g) bottles. The recall affects 26 bottles with lot code A-01, manufactured for and distributed by Claire Ellen Topicals in Westborough, Massachusetts.
The recall was initiated due to deviations from current Good Manufacturing Practice (cGMP) standards. No illnesses or injuries have been reported in association with this product.
The product was distributed nationwide in the United States and to Australia. Consumers who have purchased this product should discontinue use and contact the manufacturer for guidance on return or disposal.
The recalled product
- Product
- Menastil, A Homeopathic Formula, Calendula Oil packaged in 1/8 Fl. oz. (3.5 g) bottles, Mfg. for/Dist. By Claire Ellen Topicals, P.O. Box 901 Westborough, MA 01581, USA, NDC# 66233-711-01.
- Manufacturer
- Atlantic Management Resources Ltd.
- Category
- Drug — Homeopathic
- Hazard
- gmp-deviation
- manufacturing-practice
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot Code A-01
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27